Journals / Turkish Journal of Pharmaceutical Sciences / 2020 / Cilt: 17 - Sayı: 6

Antifungal and Antibiofilm Activities of Selective Serotonin Reuptake Inhibitors Alone and in Combination with Fluconazole

Selektif Serotonin Geri Alım İnhibitörlerinin Tek Başına ve Flukonazol ile Kombinasyonlarının Antifungal ve Antibiyofilm Aktiviteleri

Pages
667–672
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

SRT and FLX alone or incombination with antifungals may possibly have therapeutic potential for combating fungal infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Candida spp. are clinically important pathogens that cause difficulties for treatment by biofilm formation.
📊
Key Findings & Data:Considering antifungalresistance rates and the limitations in the discovery of new antifungals, the antifungal and antibiofilm effects of various drugs used for differenttherapeutic purposes are becoming more important.
💡
Conclusion & Impact:SRT and FLX alone or incombination with antifungals may possibly have therapeutic potential for combating fungal infections.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Candida spp. are clinically important pathogens that cause difficulties for treatment by biofilm formation. Considering antifungalresistance rates and the limitations in the discovery of new antifungals, the antifungal and antibiofilm effects of various drugs used for differenttherapeutic purposes are becoming more important. The goal of our study was to determine the antifungal and antibiofilm effects of the selectiveserotonin reuptake inhibitors (SSRIs), namely sertraline (SRT), paroxetine (PRX), and fluoxetine (FLX) alone and in combination with fluconazole(FLC) against Candida spp.Materials and Methods: Twenty Candida spp. strains isolated from clinical samples from Ege University Hospital were identified by the Dalmaumethod and matrix-assisted laser desorption ionization time of flight mass spectrometry. The minimum inhibitory concentrations (MICs) of the SSRIsand FLC were detected by broth microdilution method. Synergistic interactions between the SSRIs and FLC were investigated by checkerboardassay. The antibiofilm effects of the SSRIs were determined by spectrophotometric microplate method.Results: Among the isolates, five different Candida spp. (C. albicans, C. glabrata, C. krusei, C. tropicalis, and C.parapsilosis) were identified. The MICsof the SSRIs ranged between 16-512 µg/mL. While SRT showed the highest antifungal effect, the antibiofilm efficacy of FLX was higher than that ofthe other agents. Moreover, FLX and PRX showed a synergistic effect with FLC in 13 and 19 isolates, respectively. Four isolates were strong biofilmproducers while nine isolates were moderate biofilm producers. C. parapsilosis strains showed higher biofilm production than the other species.At MIC/2 concentration, FLX and SRT alone inhibited mature biofilms in six and five isolates, respectively, while PRX caused increases biofilmformation in seven isolates.Conclusion: This study revealed that MIC/2 concentrations of SSRIs could have antifungal and antibiofilm effects. SRT and FLX alone or incombination with antifungals may possibly have therapeutic potential for combating fungal infections.

Özet

Amaç: Klinik açıdan önemli fungal patojenlerden olan Candida türleri, biyofilm üretme kapasiteleriyle tedavide zorluklara yol açmaktadır. Antifungal direnç oranları ve yeni antifungallerin keşfinin sınırlılığı göz önüne alındığında, farklı terapötik amaç için kullanılan çeşitli ilaç moleküllerinin antifungal ve antibiyofilm etkileri daha fazla önem kazanmaktadır. Çalışmamızın amacı, selektif serotonin geri alım inhibitörleri (SSRI) olan sertralin (SRT), paroksetin (PRX), fluoksetinin (FLX), tek başına ve flukonazol (FLC) ile kombine halde Candida türlerine karşı antifungal ve antibiyofilm etkilerinin belirlenmesidir

🔖

Cite This Article

TEMEL, A., TEKİNTAŞ, Y., POLAT, S. H., METİN, D. Y., ATEŞ, A., ERAÇ, B., LİMONCU, M. H. (2022). Antifungal and Antibiofilm Activities of Selective Serotonin Reuptake Inhibitors Alone and in Combination with Fluconazole. Turkish Journal of Pharmaceutical Sciences, Cilt: 17 - Sayı: 6, 667–672. https://ajindex.com/articles/613728

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Guinea J, Sánchez-Somolinos M, Cuevas O, Peláez T, Bouza E. Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps. Med Mycol. 2006;44:575-578.
  2. Shin JH, Kee SJ, Shin MG, Kim SH, Shin DH, Lee SK, Suh SP, Ryang DW. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: Comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol. 2002;40:1244-1248.
  3. Paulone S, Ardizzoni A, Tavanti A, Piccinelli S, Rizzato C, Lupetti A, Colombari B, Pericolini E, Polonelli L, Magliani W, Conti S, Posteraro B, Cermelli C, Blasi E, Peppoloni S. The synthetic killer peptide KP impairs Candida albicans biofilm in vitro. PLoS One. 2017;12:1-16.
  4. Gao Y, Li H, Liu S, Zhang X, Sun S. Synergistic effect of fluconazole and doxycycline against Candida albicans biofilms resulting from calcium fluctuation and downregulation of fluconazole-inducible efflux pump gene overexpression. J Med Microbiol. 2014;63:956-961.
  5. Pesee S, Angkananuwat C, Tancharoensukjit S, Muanmai S, Sirivan P, Bubphawas M, Tanarerkchai N. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm. Med Mycol. 2016;54:384-393.
  6. Lass-Flörl C, Dierich MP, Fuchs D, Semenitz E, Ledochowski M. Antifungal activity against Candida species of the selective serotoninreuptake inhibitor, sertraline. Clin Infect Dis. 2001;33:135-136. Def EE. EUCAST E.DEF 7.3.1. EUCAST Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts 2017; (January). Available from: https://www.eucast.org/ astoffungi/publications_in_journals/ Lewis RE, Diekema DJ, Messer SA, Pfaller MA, Klepser ME. Comparison of E-test, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother. 2002;49:345-351.
  7. Madariaga-Venegas F, Fernández-Soto R, Duarte LF, Suarez N, Delgadillo D, Jara JA, Fernández-Ramires R, Urzúa B, Molina-Berríos A. Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients. PLoS One. 2017;12:e0176755. Pfaller MA, Castanheira M, Messer SA, Rhomberg PR, Jones RN. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. Diagn Microbiol Infect Dis. 201